Know Labs (NYSEAMERICAN:KNW) Stock Price Up 3.8% – Time to Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) rose 3.8% on Friday . The stock traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares changed hands during trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Price Performance

The firm has a fifty day simple moving average of $2.14 and a two-hundred day simple moving average of $2.14. The firm has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83.

Hedge Funds Weigh In On Know Labs

A hedge fund recently bought a new stake in Know Labs stock. Cerity Partners LLC acquired a new stake in shares of Know Labs, Inc. (NYSEAMERICAN:KNW) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 80,000 shares of the company’s stock, valued at approximately $158,000. Cerity Partners LLC owned 1.07% of Know Labs at the end of the most recent quarter. Institutional investors and hedge funds own 23.96% of the company’s stock.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.